Loading
A phase 3 trial of Degarelix, Goserelin / leuprolide and Bicalutamide in Prostate cancer, run by Ferring Pharmaceuticals, completed.
Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients is a phase 3 interventional study registered as NCT00884273 by Ferring Pharmaceuticals, with 182 participants recorded, started 2009-08 and reaching its primary completion in 2011-03. Interventions recorded: Degarelix, Goserelin, Bicalutamide. Conditions recorded: Prostate Cancer.
Linked to the drug Degarelix because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.
Numbers are from the trial as recorded here; see the source links in the table below. This is orientation, not medical advice: ask your team how closely the trial population matches you.
182 enrolled.
SD 16.8; Figures from the ClinicalTrials.gov results section (first posted 2012-04-11), not from a publication · SD 17.7
Source| Endpoint | Arm | n | Value | HR (95% CI) | p | Source |
|---|---|---|---|---|---|---|
| Change From Baseline in Prostate Size Based on Trans Rectal Ultra Sound (TRUS) at Week 12 (Full Analysis Set)primary | Degarelix 240 mg/80 mg | 82 | -37.2 milliliter | - | 0.36 | link |
| Goserelin (3.6 mg) + Bicalutamide (50 mg) | 97 | -39 milliliter |
Shares Ferring Pharmaceuticals, Degarelix, Bicalutamide, Goserelin / leuprolide (ovarian function suppression) and the tag pipeline.
Shares Ferring Pharmaceuticals, Degarelix, Prostate cancer and the tag pipeline.
Shares Degarelix, Bicalutamide, Goserelin / leuprolide (ovarian function suppression), Prostate cancer and the tag pipeline.
Shares Bicalutamide, Goserelin / leuprolide (ovarian function suppression), Prostate cancer and the tag pipeline.
Shares Degarelix, Bicalutamide, Goserelin / leuprolide (ovarian function suppression), Prostate cancer and the tag pipeline.
Shares Degarelix, Bicalutamide, Prostate cancer and the tag pipeline.
Shares Degarelix, Bicalutamide, Goserelin / leuprolide (ovarian function suppression), Prostate cancer and the tag pipeline.
Shares Ferring Pharmaceuticals and the tag pipeline.